Insider Transactions Reported by 28 Insiders of STANDARD BIOTOOLS INC.

Symbol
LAB on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

STANDARD BIOTOOLS INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eli Casdin Director, 10%+ Owner $113,818,299 26 Feb 2026
Casdin Partners Master Fund, L.P. Director, 10%+ Owner $107,795,554 +$16,303,018 +18% 02 Dec 2025
VIKING GLOBAL INVESTORS LP 10%+ Owner $53,225,865 18 Mar 2024
Caligan Partners LP 10%+ Owner $34,539,714 29 Jun 2023
Michael Egholm President & CEO, Director $13,261,285 -$15,137 -0.11% 23 Feb 2026
Hanjoon Alex Kim Chief Financial Officer $4,741,242 -$4,151 -0.09% 23 Feb 2026
Jeffrey G. Black SVP & Chief Financial Officer $2,532,070 20 Aug 2024
Sean Mackay SVP & Chief Business Officer $2,454,350 -$38,221 -1.5% 23 Feb 2026
Casdin Amplify Fund, LP Director $1,117,250 18 Jun 2024
Stephen Christopher Linthwaite President & CEO $1,004,213 22 Feb 2022
Vikram Jog Chief Financial Officer $762,479 21 Feb 2023
Troy Cox Director $710,682 26 Feb 2026
Thomas D. Carey Director $692,160 26 Feb 2026
Jeremy Steven Davis SVP Chief Commercial Officer $667,438 21 Feb 2023
Fenel M. Eloi Director $520,430 20 Jun 2025
Nicolas Barthelemy Director $518,356 01 Apr 2022
Frank Witney Director $498,068 20 Jun 2025
Carlos Paya V Director $454,505 14 Jun 2023
Kathy L. Hibbs Director $416,060 20 Jun 2025
Gerhard F. Burbach Director $405,157 15 Jun 2022
Laura Clague Director $398,490 14 Jun 2023
Martin D. Madaus Director $396,763 20 Oct 2023
Bradley Allen Kreger SVP, Global Operations $381,265 20 May 2022
Nicholas Khadder SVP, Gen. Counsel & Secretary $336,457 31 May 2022
Bill Colston Director $309,808 15 Jun 2022
Colin McCracken Chief Commercial Officer $201,082 22 Feb 2022
Ana K. Stankovic Director $104,753 25 May 2021
Casdin Partners FO1-MSV, LP Director 17 May 2023

Recent Insider Transactions by Companies or Individuals for STANDARD BIOTOOLS INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Eli Casdin LAB Common Stock Award 1.83% 52,991 2,954,053 26 Feb 2026 Direct
Troy Cox LAB Common Stock Award 17.9% 57,264 376,586 26 Feb 2026 Direct
Thomas D. Carey LAB Common Stock Award 26.4% 51,282 245,340 26 Feb 2026 Direct
Michael Egholm LAB Common Stock Tax liability -1.18% -66,127 5,551,710 23 Feb 2026 Direct
Sean Mackay LAB Common Stock Tax liability -2.52% -19,661 760,174 23 Feb 2026 Direct
Hanjoon Alex Kim LAB Common Stock Tax liability -0.53% -12,740 2,407,346 23 Feb 2026 Direct
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.21% $217,020 $1.45 150,000 72,100,000 04 Dec 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.1% $108,038 $1.44 75,000 71,950,000 03 Dec 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.17% $177,512 $1.42 125,000 71,875,000 02 Dec 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 11.8% $9,838,405 $1.30 7,550,000 71,750,000 25 Nov 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.23% $214,875 $1.43 150,000 64,200,000 24 Nov 2025 See footnote
Michael Egholm LAB Common Stock Tax liability -1.12% -63,529 5,617,837 20 Nov 2025 Direct
Hanjoon Alex Kim LAB Common Stock Tax liability -0.52% -12,739 2,415,086 20 Nov 2025 Direct
Sean Mackay LAB Common Stock Tax liability -2.46% -19,661 779,835 20 Nov 2025 Direct
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.71% $586,260 $1.30 450,000 64,050,000 20 Nov 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.55% $448,910 $1.28 350,000 63,600,000 19 Nov 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.44% $339,405 $1.23 275,000 63,250,000 18 Nov 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.36% $275,580 $1.22 225,000 62,975,000 17 Nov 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.4% $309,800 $1.24 250,000 62,750,000 14 Nov 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.73% $541,395 $1.20 450,000 62,500,000 13 Nov 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.61% $445,838 $1.19 375,000 62,050,000 12 Nov 2025 See Footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.49% $358,800 $1.20 300,000 61,675,000 11 Nov 2025 See Footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.45% $321,915 $1.17 275,000 61,375,000 10 Nov 2025 See Footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.37% $252,765 $1.12 225,000 61,100,000 07 Nov 2025 See Footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.16% $128,920 $1.29 100,000 60,875,000 09 Sep 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.41% $319,350 $1.28 250,000 60,775,000 04 Sep 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.41% $316,400 $1.27 250,000 60,525,000 03 Sep 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.21% $157,938 $1.26 125,000 60,275,000 26 Aug 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.33% $248,180 $1.24 200,000 60,150,000 25 Aug 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock, $0.001 par value per share Purchase 0.33% $252,680 $1.26 200,000 59,950,000 22 Aug 2025 See footnote
Michael Egholm LAB Common Stock Tax liability -0.96% -54,919 5,681,366 20 Aug 2025 Direct
Sean Mackay LAB Common Stock Tax liability -2.4% -19,661 799,496 20 Aug 2025 Direct
Hanjoon Alex Kim LAB Common Stock Tax liability -0.52% -12,739 2,427,825 20 Aug 2025 Direct
Casdin Partners Master Fund, L.P. LAB Common Stock Purchase 0.25% $183,210 $1.22 150,000 59,750,000 15 Aug 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock Purchase 0.22% $161,543 $1.21 133,220 59,600,000 14 Aug 2025 See footnote
Casdin Partners Master Fund, L.P. LAB Common Stock Purchase 0.13% $98,280 $1.31 75,000 59,466,780 13 Aug 2025 See footnote
Hanjoon Alex Kim LAB Common Stock Award 159.5% 1,500,000 2,440,564 01 Aug 2025 Direct
Michael Egholm LAB Common Stock Award 109.6% 3,000,000 5,736,285 01 Aug 2025 Direct
Fenel M. Eloi LAB Common Stock Award 66.8% 94,592 236,183 20 Jun 2025 Direct
Fenel M. Eloi LAB Stock Option (Right to buy) Award 125,660 125,660 20 Jun 2025 Direct
Thomas D. Carey LAB Common Stock Award 95.1% 94,592 194,058 20 Jun 2025 Direct
Thomas D. Carey LAB Stock Option (Right to buy) Award 188,490 188,490 20 Jun 2025 Direct
Eli Casdin LAB Common Stock Award 3.37% 94,592 2,901,062 20 Jun 2025 Direct
Eli Casdin LAB Stock Option (Right to buy) Award 125,660 125,660 20 Jun 2025 Direct
Kathy L. Hibbs LAB Common Stock Award 219.3% 94,592 137,720 20 Jun 2025 Direct
Kathy L. Hibbs LAB Stock Option (Right to buy) Award 125,660 125,660 20 Jun 2025 Direct
Frank Witney LAB Common Stock Award 81.4% 94,592 210,862 20 Jun 2025 Direct
Frank Witney LAB Stock Option (Right to buy) Award 125,660 125,660 20 Jun 2025 Direct
Sean Mackay LAB Common Stock Tax liability -2.84% -23,919 819,157 28 May 2025 Direct
Michael Egholm LAB Common Stock Tax liability -0.36% -9,906 2,731,285 28 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.